GP
Grant Pickering
Chief Executive Officer, Director and Co-Founder
VaxCyteVaxCyte Pipeline
| Drug | Indication | Phase |
|---|
| VAX-31 | Invasive Pneumococcal Disease (Adults) | Phase 3 |
| VAX-24 | Invasive Pneumococcal Disease (Infants) | Phase 2 |
| VAX-XL | Invasive Pneumococcal Disease | Pre-clinical |
| VAX-A1 | Group A Strep | Pre-clinical |
| VAX-GI | Shigella | Pre-clinical |
